Changes in therapeutic strategy in metastatic castration resistant prostate cancer between 2012 and 2014 from the French nationwide claims database

被引：0
|
作者：
Thurin, Nicolas H. [1 ]
Rouyer, Magali [1 ]
Jove, Jeremy [1 ]
Gross-Goupil, Marine [2 ]
Haaser, Thibaud [2 ]
Rebillard, Xavier [3 ]
Soulie, Michel [4 ]
de Pouvourville, Gerard [5 ]
Capone, Camille [6 ]
Pierres, Marie [6 ]
Lamarque, Stephanie [1 ]
Bignon, Emmanuelle [1 ]
Droz-Perroteau, Cecile [1 ]
Moore, Nicholas [1 ,2 ]
Blin, Patrick [1 ]
机构：
[1] Univ Bordeaux, Bordeaux PharmacoEpi, INSERM, CIC1401, Bordeaux, France
[2] CHU Bordeaux, Bordeaux, France
[3] Clin Beau Soleil, Montpellier, France
[4] CHU Toulouse, Toulouse, France
[5] ESSEC, Cergy Pontoise, France
[6] Janssen, Issy Les Moulineaux, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4343
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [21] Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer
    Jang, Albert
    Sartor, Oliver
    Barata, Pedro C.
    Paller, Channing J.
    CANCERS, 2020, 12 (11) : 1 - 14
  • [22] Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
    Coleman, Ilsa M.
    DeSarkar, Navonil
    Morrissey, Colm
    Xin, Li
    Roudier, Martine P.
    Sayar, Erolcan
    Li, Dapei
    Corey, Eva
    Haffner, Michael C.
    Nelson, Peter S.
    CLINICAL CANCER RESEARCH, 2022, 28 (14) : 3127 - 3140
  • [23] Current therapeutic options targeting bone metastasis in metastatic castration resistant prostate cancer
    Fragkoulis, Charalampos
    Gkialas, Ioannis
    Papadopoulos, Georgios
    Ntoumas, Konstantinos
    JOURNAL OF BUON, 2016, 21 (04): : 787 - 791
  • [24] MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
    Nicholas G. Nickols
    Ramin Nazarian
    Shuang G. Zhao
    Victor Tan
    Vladislav Uzunangelov
    Zheng Xia
    Robert Baertsch
    Elad Neeman
    Allen C. Gao
    George V. Thomas
    Lauren Howard
    Amanda M. De Hoedt
    Josh Stuart
    Theodore Goldstein
    Kim Chi
    Martin E. Gleave
    Julie N. Graff
    Tomasz M. Beer
    Justin M. Drake
    Christopher P. Evans
    Rahul Aggarwal
    Adam Foye
    Felix Y. Feng
    Eric J. Small
    William J. Aronson
    Stephen J. Freedland
    Owen N. Witte
    Jiaoti Huang
    Joshi J. Alumkal
    Robert E. Reiter
    Matthew B. Rettig
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 531 - 538
  • [25] COST EFFECTIVENESS OF NEW THERAPEUTIC OPTIONS IN CASTRATION-RESISTANT METASTATIC PROSTATE CANCER
    Kostyuk, A.
    Akanov, A.
    VALUE IN HEALTH, 2016, 19 (03) : A151 - A151
  • [26] Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?
    Slootbeek, Peter H. J.
    Tolmeijer, Sofie H.
    Mehra, Niven
    Schalken, Jack A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (03) : 178 - 204
  • [27] PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape
    Al-Akhras, Ashaar
    Chehade, Chadi Hage
    Narang, Arshit
    Swami, Umang
    LIFE-BASEL, 2024, 14 (02):
  • [28] MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
    Nickols, Nicholas G.
    Nazarian, Ramin
    Zhao, Shuang G.
    Tan, Victor
    Uzunangelov, Vladislav
    Xia, Zheng
    Baertsch, Robert
    Neeman, Elad
    Gao, Allen C.
    Thomas, George, V
    Howard, Lauren
    De Hoedt, Amanda M.
    Stuart, Josh
    Goldstein, Theodore
    Chi, Kim
    Gleave, Martin E.
    Graff, Julie N.
    Beer, Tomasz M.
    Drake, Justin M.
    Evans, Christopher P.
    Aggarwal, Rahul
    Foye, Adam
    Feng, Felix Y.
    Small, Eric J.
    Aronson, William J.
    Freedland, Stephen J.
    Witte, Owen N.
    Huang, Jiaoti
    Alumkal, Joshi J.
    Reiter, Robert E.
    Retti, Matthew B.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (04) : 531 - 538
  • [29] Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancer
    Unda-Urzaiz, M.
    Sousa-Campo, R.
    Rodriguez-Antolin, A.
    Silva-Marins, C.
    Juarez-Soto, A.
    Minana-Lopez, B.
    Figueiredo-de Castro, A.
    Cozar-Olmos, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (04): : 227 - 237
  • [30] The correlation between metastasis-free survival and overall survival in non-metastatic castration resistant prostate cancer patients from the Medical Data Vision claims database in Japan
    Mori, Asuka
    Hashimoto, Kohei
    Koroki, Yosuke
    Wu, David Bin-Chia
    Masumori, Naoya
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (10) : 1745 - 1750
12345